SAN DIEGO, Oct. 10, 2018 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Imperva, Inc. ("Imperva") (NASDAQ: IMPV) breached their fiduciary duties in connection with the proposed sale of the Company to Thoma Bravo, LLC ("Thoma Bravo).
On October 10, 2018, Imperva announced that it had signed a definitive merger agreement with Thoma Bravo. Under the terms of the transaction, Imperva shareholders will receive $55.75 a share per share in cash for each share of Imperva held.
The investigation concerns whether the Imperva board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Imperva shares of common stock. Nationally recognized Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given one Wall Street analyst has a $65.00 price target on the stock.
If you are a shareholder of Imperva and believe the proposed buyout price is too low or you're interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker (firstname.lastname@example.org) at 619-814-4471. If emailing, please include a phone number.
Additionally, you can [Click here to join this action]. There is no cost or obligation to you.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.
SOURCE Johnson Fistel, LLP